We are live on ! Find out more
EC

EntryPoint Capital Portfolio holdings

AUM $412M
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+15.49%
1 Year Est. Return
+28.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$412M
AUM Growth
+$70.8M
Cap. Flow
+$36.5M
Cap. Flow %
8.87%
Top 10 Hldgs %
4.34%
Holding
1,002
New
271
Increased
170
Reduced
168
Closed
234

Top Buys

Rank Stock Value
1
HBAN icon
Huntington Bancshares
HBAN
+$1.67M
2
DCI icon
Donaldson
DCI
+$1.6M
3
FDX icon
FedEx
FDX
+$1.6M
4
FNF icon
Fidelity National Financial
FNF
+$1.53M
5
GGG icon
Graco
GGG
+$1.51M

Top Sells

Rank Stock Value
1
CDNS icon
Cadence Design Systems
CDNS
+$1.48M
2
TIC
TIC Solutions Inc
TIC
+$1.48M
3
SDGR icon
Schrodinger
SDGR
+$1.27M
4
EXC icon
Exelon
EXC
+$1.23M
5
VC icon
Visteon
VC
+$1.22M

Sector Composition

Rank Sector Weight
1 Industrials 18.1%
2 Financials 16.8%
3 Healthcare 15.07%
4 Technology 12.86%
5 Consumer Discretionary 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
801
Berkshire Hathaway Class B
BRK.B
$1.08T
-1,395
Closed -$668K
BSY icon
802
Bentley Systems
BSY
$10.2B
-7,983
Closed -$280K
BW icon
803
Babcock & Wilcox
BW
$1.06B
-16,286
Closed -$239K
BX icon
804
Blackstone
BX
$102B
-8,990
Closed -$1.03M
CBZ icon
805
CBIZ
CBZ
$2.98B
-24,002
Closed -$644K
CECO icon
806
Ceco Environmental
CECO
$4.34B
-3,770
Closed -$225K
CERT icon
807
Certara
CERT
$1.21B
-69,491
Closed -$396K
CHE icon
808
Chemed
CHE
$6.79B
-894
Closed -$338K
CLDX icon
809
Celldex Therapeutics
CLDX
$3.12B
-7,430
Closed -$236K
CLFD icon
810
Clearfield
CLFD
$389M
-15,447
Closed -$409K
CLNE icon
811
Clean Energy Fuels
CLNE
$364M
-40,338
Closed -$100K
CMP icon
812
Compass Minerals
CMP
$1.06B
-14,021
Closed -$327K
CMPX icon
813
Compass Therapeutics
CMPX
$429M
-29,265
Closed -$155K
CNM icon
814
Core & Main
CNM
$8.3B
-18,179
Closed -$898K
COLD icon
815
Americold
COLD
$4.06B
-17,987
Closed -$206K
COLM icon
816
Columbia Sportswear
COLM
$2.95B
-5,060
Closed -$277K
CPB icon
817
Campbell Soup
CPB
$6.38B
-19,524
Closed -$435K
CPRX
818
DELISTED
Catalyst Pharmaceutical
CPRX
-19,539
Closed -$484K
CR icon
819
Crane Co
CR
$11.8B
-2,768
Closed -$473K
CRM icon
820
Salesforce
CRM
$213B
-1,489
Closed -$278K
CRSR icon
821
Corsair Gaming
CRSR
$1.38B
-88,765
Closed -$493K
CRWD icon
822
CrowdStrike
CRWD
$218B
-2,412
Closed -$235K
CTSH icon
823
Cognizant
CTSH
$28.1B
-3,993
Closed -$245K
CWH icon
824
Camping World
CWH
$444M
-17,539
Closed -$120K
D icon
825
Dominion Energy
D
$57.9B
-4,558
Closed -$282K

Similar funds

EntryPoint Capital's Q2 2026 Portfolio in Review

As of Q2 2026, EntryPoint Capital held 1,002 positions worth $412M, up 21% from $341M the previous quarter. Its ten largest holdings account for 4.3% of the portfolio.

EntryPoint Capital deployed $36.5M of net new capital in Q2 2026, opening 271 new positions and adding to 170 existing holdings. Its largest new stake was Huntington Bancshares: 101,010 shares worth $1.79M.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Cadence Design Systems, an estimated $1.48M trimmed.

  • EntryPoint Capital's largest Q2 2026 buy was Huntington Bancshares: 101,010 shares worth $1.79M.
  • EntryPoint Capital added most to Gilead Sciences in Q2 2026, an estimated $1.51M increase.
  • EntryPoint Capital's biggest Q2 2026 reduction was Cadence Design Systems, cutting an estimated $1.48M.
  • EntryPoint Capital fully exited Exelon in Q2 2026, selling an estimated $1.23M.
  • EntryPoint Capital's ten largest holdings make up 4.3% of its $412M portfolio in Q2 2026.
  • EntryPoint Capital opened 271 new positions and closed 234 in Q2 2026.
  • EntryPoint Capital's portfolio value rose 21% quarter-over-quarter to $412M.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.